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Ubiquitin binding proteins regulate the stability,
function, and/or localization of ubiquitinated
proteins. Here we report the crystal structures
of the zinc-finger ubiquitin binding domain (ZnF
UBP) from the deubiquitinating enzyme isopep-
tidase T (IsoT, or USP5) alone and in complex
with ubiquitin. Unlike other ubiquitin binding
domains, this domain contains a deep binding
pocket where the C-terminal diglycine motif of
ubiquitin is inserted, thus explaining the speci-
ficity of IsoT for an unmodified C terminus on
the proximal subunit of polyubiquitin. Mutations
in the domain demonstrate that it is required for
optimal catalytic activation of IsoT. This domain
is present in several other protein families, and
the ZnF UBP domain from an E3 ligase also re-
quires the C terminus of ubiquitin for binding.
These data suggest that binding the ubiquitin
C terminus may be necessary for the function
of other proteins.
INTRODUCTION
Ubiquitin is a highly conserved 76 residue protein whose
conjugation to substrate proteins acts as a signal to
alter protein localization or function and/or to regulate
protein-protein interactions (Hershko and Ciechanover,
1998; Hicke, 2001; Pickart, 2004; Sun and Chen, 2004).
Ubiquitin is conjugated to target proteins via an isopeptide
bond formed between its C-terminal residue (G76) and
a side-chain lysine on the target protein. Conjugation of
a single ubiquitin to target proteins is required for diverse
processes such as receptor-mediated signaling, endocy-
tosis, viral budding, and maintenance of chromatin (Sigis-
mund et al., 2004). Additionally, any of seven ubiquitin ly-
sines can be utilized to form an isopeptide bond to another
ubiquitin (Pickart and Fushman, 2004), resulting in poly-
ubiquitin chains having different conformations (VaradanCet al., 2004). One of the best understood functions of poly-
ubiquitin is to direct proteins to the proteasome to be de-
graded (Welchman et al., 2005). The canonical degrada-
tion signal is composed of four or more ubiquitins linked
through K48 on ubiquitin. Linkage of polyubiquitin through
other lysines appears to target proteins for nondegrada-
tive fates. Polyubiquitin chains have polarity: The proximal
end is defined as the end proximal to the target protein to
which it is conjugated (or, in unanchored chains, the end
that contains a free C terminus), while the distal end is
the end farthest from the conjugated substrate.
A number of ubiquitin binding domains have been de-
scribed, and, in some cases, the molecular details of the
interactions are known (Alam et al., 2004; Davies et al.,
2003; Hicke et al., 2005; Mueller et al., 2004; Ohno et al.,
2005; Prag et al., 2003, 2005; Sundquist et al., 2004;
Swanson et al., 2003). Most of these proteins contact
the hydrophobic face of ubiquitin, centered on I44; how-
ever, recently, two new ubiquitin binding domains were
reported to contact ubiquitin through surfaces that are
not centered on I44 (Bienko et al., 2005; Lee et al., 2006;
Penengo et al., 2006 [this issue of Cell]).
The recognition of ubiquitin by deubiquitinating en-
zymes (DUBs) provides a model for understanding the
binding of other ubiquitin binding proteins. DUBs are pro-
teases that hydrolyze the isopeptide bond between ubiq-
uitin and target proteins (Amerik and Hochstrasser, 2004;
Wilkinson, 1997) and between adjacent ubiquitins in poly-
ubiquitin chains, thereby recycling free ubiquitin (Amerik
et al., 1997; Doelling et al., 2001; Lindsey et al., 1998).
The disassembly of polyubiquitin chains is necessary to
avoid their accumulation, which can inhibit the protea-
some (Amerik et al., 1997; Lam et al., 2000). Human iso-
peptidase T (IsoT or USP5) is a homolog of S. cerevisiae
UBP14, which is responsible for the disassembly of the
majority of unanchored polyubiquitin chains (Amerik
et al., 1997). IsoT nonprocessively disassembles unan-
chored chains, releasing one ubiquitin at a time from the
proximal end of the chain. Modification of the proximal
ubiquitin’s C terminus by esterification or removal of G76
markedly reduces the rate of cleavage by IsoT (Wilkinson
et al., 1995).ell 124, 1197–1208, March 24, 2006 ª2006 Elsevier Inc. 1197
IsoT-mediated hydrolysis of ubiquitin amidomethyl
coumarin (Ub-AMC) is stimulated by low concentrations
of free monoubiquitin with an unmodified C terminus, sug-
gesting the presence of an activation domain in IsoT (Dang
et al., 1998). The requirement for an unmodified C termi-
nus in monoubiquitin to activate Ub-AMC hydrolysis and
the requirement for an unmodified C terminus to achieve
efficient hydrolysis of unanchored polyubiquitin chains
(Wilkinson et al., 1995) suggest that the activation domain
is the site that interacts with the proximal ubiquitin in poly-
ubiquitin chains.
Figure 1A depicts the four putative ubiquitin binding do-
mains of IsoT: the UBP (ubiquitin-specific processing pro-
tease) catalytic domain formed by noncontiguous regions
containing the active-site Cys and His box (Amerik et al.,
1997), two ubiquitin-associated (UBA) domains, and a
zinc-finger ubiquitin binding domain (ZnF UBP). The latter
domain is also known as the polyubiquitin-associated zinc
finger (PAZ) domain (Hook et al., 2002; Seigneurin-Berny
et al., 2001). The prevailing model is that, together, these
domains coordinate the binding and hydrolysis of polyubi-
quitin chains; at least one domain comprises the S10 site
and binds the proximal ubiquitin, thus activating hydrolysis
at the active site (Figure 1B). The others form the S1–S3
sites and bind the distal ubiquitins on the chain (Wilkinson
etal., 1995).ForUb-AMChydrolysis, theubiquitinmoietyof
Ub-AMCbinds to the S1 (catalytic) site, and freemonoubi-
quitin binds the activationorS10 site (Figure 1C). In both as-
says, occupancy of the S10 site by ubiquitin bearing a free
C terminus is thought to be necessary for optimal activity.
Here we show structurally and biochemically that the
ZnF UBP domain of IsoT is the S10 site and, as such, is re-
sponsible for recognizing the diglycine motif on the C ter-
minus of unanchored polyubiquitin chains. The ZnF UBP
domain is present in several conserved protein families:
deubiquitinating enzymes such as mammalian USP3,
USP5, USP13, USP44, USP45, USP49, and USP51 and
S. cerevisiae UBP8; a RING E3 ligase (known as IMP, im-
pedes mitogenic signal progression, or BRAP2, BRCA1-
associated protein 2); and HDAC6, a microtubule deace-
tylase (Amerik et al., 2000; Ingvarsdottir et al., 2005; Li
et al., 1998; Matheny et al., 2004; Quesada et al., 2004;
Seigneurin-Berny et al., 2001). We find that the ZnF UBP
domain of the S. cerevisiae homolog of human IMP
(scIMP, or YHL010c) binds ubiquitin and requires the C-
terminal glycine of ubiquitin for binding, suggesting that
this novel mode of binding is conserved among ZnF
UBP domains. The present study represents the structural
and biochemical characterization of a ZnF UBP domain
and has important implications for understanding the
function of other proteins containing this domain.
RESULTS
The Activation Domain, S10 Site, of IsoT Binds
Monoubiquitin Tightly
To quantitate the binding of monoubiquitin to IsoT, we de-
veloped a binding assay utilizing fluorescence anisotropy1198 Cell 124, 1197–1208, March 24, 2006 ª2006 Elsevier Inc.measurements. The fluorescent probe (IA-Ub) consists of
a K48Cmutant monoubiquitin labeled with a thiol-reactive
fluorescent dye (see Experimental Procedures). IsoT
binds IA-Ub, and this binding can be competed by mono-
ubiquitin but not Ub1–75, a mutant ubiquitin lacking the
C-terminal glycine (Figures 1D and 1E, respectively). The
competitive binding suggests that IA-Ub andmonoubiqui-
tin bind to the same site on IsoT with similar binding con-
stants—75 ± 2 nM and 72 ± 9 nM, respectively—and that
this binding requires an unmodifiedC terminus. In the con-
text of binding to unanchored polyubiquitin chains, these
data suggest that this monoubiquitin binding domain
forms the S10 pocket responsible for recognizing the pres-
ence of an unmodified free C terminus.
The Activation Domain, S10 Site, of IsoT Is the ZnF
UBP Domain
To identify the domain of IsoT that requires an unmodified
ubiquitin C terminus for binding, we performed tryptic
proteolysis on the purified, recombinant full-length IsoT
and identified a 15 kDa fragment capable of binding to
an affinity column containing wild-type monoubiquitin
but not to a column containing G76C monoubiquitin (see
Figure S1A in the Supplemental Data available with this
article online). Using mass spectrometry and N-terminal
sequencing, we determined that the isolated 15 kDa frag-
ment is comprised of amino acids 163–291, correspond-
ing to the ZnF UBP domain of IsoT. The recombinant
IsoT ZnF UBP domain retains the property of binding to
an unmodified ubiquitin C terminus (Figure S1B). Wemea-
sured the binding affinity between the ZnF UBP domain
and ubiquitin by isothermal titration calorimetry (ITC).
The domain bound a single molecule of ubiquitin (KD =
2.82 ± 0.09 mM, DHapparent = 20.9 ± 0.3 kcal/mol, and
DSapparent =44 ± 1 cal/mol/deg) (Figure 1F). This binding
is tighter than that of most other isolated ubiquitin binding
domains (10–500 mM) (Hicke et al., 2005). However, the
binding is 30-fold weaker than that of full-length IsoT,
suggesting that the region (or regions) outside of the ZnF
UBP domain also contributes to the binding affinity for
monoubiquitin.
Structure of the IsoT ZnF UBP Domain
We crystallized the ZnF UBP domain of IsoT and deter-
mined its structure to a resolution of 2.09 A˚ (Table S1).
The domain crystallizes as a disulfide-linked dimer (see
Discussion), but, as both molecules in the unit cell are
identical, we will discuss only the monomeric structure.
The ZnF UBP domain mainly consists of five antiparallel
b strands (2[ 1Y 3[ 4Y 5[), with a topological switch be-
tween strands b1 and b3, and two a helices, with helix aA
on one side of strands b1 and b2 and helix aB on the other
side of strands b3 to b5 (Figures 2A–2B). The domain
adopts a compact fold with a deep pocket formed pre-
dominantly by residues of strands b1 and b4 and loop
L2A; Y261 lies in the bottom of the pocket, while W209,
Y259, and the guanidine group of R221 line the sides of
pocket (Figures 2C). One zinc ion is chelated tetrahedrally
Figure 1. The C Terminus of Ubiquitin Is Required for Binding to the Activation Domain of IsoT
(A) IsoT ubiquitin binding domains. The UBP domain consists of the Cys and His box depicted in black.
(B) Putative binding of K48-linked tetraubiquitin to IsoT. The proximal ubiquitin (Ub) occupies the activation or S10site, and the distal ubiquitins occupy
the S1, S2, and S3 sites.
(C) Model of the enzymatic mechanism of IsoT using Ub-AMC as a substrate. Ub-AMC binds to the S1 or active site, and it is hydrolyzed to ubiquitin
and AMC. Free ubiquitin binds the S10site of IsoT, stimulating the hydrolysis of Ub-AMC at the S1 site.
(D) Competitive binding of IA-Ub and Ub to IsoT. IA-Ub concentration was 80 nM for all binding assays. Ub concentration was increased from 0 to
467 nM. The KD measured for IA-Ub is 75 ± 2 nM, while the KD for ubiquitin (Ub) is 72 ± 9 nM. Error bars delineate the standard deviation of three
measurements.
(E) Ub1–75does not compete with IA-Ub for binding to IsoT. IA-Ub concentration was 80 nM for all binding assays. Ub1–75 was increased from 0 to
4000 nM.
(F) Binding of IsoT ZnF UBP domain to ubiquitin as measured by ITC. Ubiquitin (1362 mM) was injected into 1.4 ml of buffer containing the ZnF UBP
domain of IsoT (50 mM) in 35 injections of 3 ml each. Controls 1, 2, and 3 consist of injecting buffer into buffer, ubiquitin into buffer, or buffer into the ZnF
UBPdomain of IsoT, respectively. The inset shows one representative titration of the ZnFUBPdomain with ubiquitin. Error bars delineate the standard
deviation of three measurements.Cell 124, 1197–1208, March 24, 2006 ª2006 Elsevier Inc. 1199
Figure 2. The ZnF UBP Domain of IsoT
(A) Ribbon diagram of the crystal structure of the IsoT ZnF UBP domain alone.
(B) Topology of the unliganded IsoT ZnF UBP domain.
(C) Surface representation of the deep hydrophobic pocket of IsoT. The ZnF UBP domain is shown in green, the aromatic residues that form the
hydrophobic pocket are colored in blue, and R221 is colored in cyan.
(D) Residues that bind to zinc. The Zn is represented as a sphere colored magenta. Residues that chelate the metal are shown as sticks colored as
follows: green, carbons; dark blue, nitrogens; orange, sulfurs.
(E) Submicromolar amounts of Ub do not activate the hydrolysis of Ub-AMC in ZnFUBPmutant IsoT. E. coli cell lysates (10 ng/ml) expressingwild-type
(WT) IsoT or ZnF UBP domain mutant IsoT were incubated with 20 nM Ub-AMC. After 100 s, 85 nM Ub was added to the reaction mixture (black
arrow). The activity of the active-site point mutant, C335A IsoT, was determined to rule out any residual activity due to proteases/esterases present in
the E. coli cell lysate. A Western blot of E. coli cell lysate expressing wild-type or mutant IsoT shows that similar amounts of IsoT point mutants were
expressed (10 mg of cell lysate per lane).
(F) C199A IsoT shows a 50-fold decrease in affinity for IA-Ub compared to WT IsoT. IsoT binds IA-Ub with a KD of 75 ± 2 nM, while C199A IsoT binds
with a KD ofR3700 nM. Error bars delineate the standard deviation of three measurements.1200 Cell 124, 1197–1208, March 24, 2006 ª2006 Elsevier Inc.
by three cysteines (C199, C202, and C219) and one histi-
dine (H232) (Figure 2D). C199 and C202 are located on
loop L1, N-terminal to strand b1, while C219 and H232
are the last and first residues of strand b2 and helix aA,
respectively.
We individually mutated the four Zn binding residues to
alanine in full-length IsoT. Like wild-type IsoT, the mutant
proteins are able to hydrolyze Ub-AMC, albeit at a slightly
slower rate (Figure 2E, first 100 s of the time course). How-
ever, unlike wild-type IsoT, none of the point mutants were
activated by the addition of free monoubiquitin (Figure 2E,
100 to 400 s of the time course). We purified one mutant
(C199A) using a ubiquitin affinity column and showed
that it exhibited decreased zinc binding (data not shown)
and a 50-fold decrease in binding affinity for IA-Ub (Fig-
ure 2F). Overall, this point mutant is correctly folded since
over 89% of C199A IsoT can react with the active-site
irreversible inhibitor ubiquitin vinyl sulfone (Ub-VS) (Fig-
ure S1C). The mutagenesis data indicate an important
structural role for the zinc atom, perhaps as a stabilizing
force for the interaction of two long loops: loop L1 and
loop L2A between strand b2 and helix aA.
Structure of the IsoT ZnF UBP Domain in Complex
with Ubiquitin
To define the nature of ubiquitin binding by the ZnF UBP
domain, we crystallized this domain of IsoT in complex
with ubiquitin (Table S2). The ZnF UBP domain/ubiquitin
complex also crystallized as a disulfide-linked dimer, but,
unlike the unliganded domain, it dimerized by domain
swapping involving the N-terminal residues 173–196
(see Discussion). Confirming our biochemical data, the
ZnF UBP domain primarily contacts the C terminus of
ubiquitin (residues L71 through G76) (Figure 3A). These
C-terminal residues form a rigid tail extending from the
globular body of ubiquitin, penetrating deeply into the hy-
drophobic pocket of the ZnF UBP domain. The 12 residue
loop L2A protrudes from the body of the ZnF UBP domain,
interacting in an antiparallel fashion with the penetrating
ubiquitin C terminus. The tip of the loop (F224) contacts
the globular surface of ubiquitin (Figure 3B), forming hy-
drophobic interactions with two aliphatic side chains (L8
and I36) of ubiquitin. A total of approximately 500 A˚2 of
surface area is occluded on each molecule upon forma-
tion of this complex. Notably, unlike many ubiquitin bind-
ing domains characterized, including UBA domains, I44 of
ubiquitin does not contact the ZnF UBP domain. Further-
more, neither the ZnF UBP domain nor the full-length IsoT
appears to require this residue for binding monoubiquitin
(data not shown and Figure S1D).
The interactions with the C terminus of ubiquitin include
an extensive network of direct andwater-mediated hydro-
gen bonds and van der Waals contacts (Figures 4A–4E).
The carboxyl oxygen atoms of ubiquitin G76 form two
direct hydrogen bonds with the amide group of R221
and the hydroxyl group of Y261, respectively (Figure 4B).
In addition, each carboxyl oxygen atom interacts with one
water molecule, w1 or w2, respectively. Water moleculeCw1 is trapped in the bottom of the pocket, forming two
additional hydrogen bonds with the backbone carbonyl
oxygen of C219, which is one of the zinc ligands, and
backbone amide of V234, which is 2 residues away from
another zinc ligand, H232. Thus, the ubiquitin G76 binding
site is directly linked to the metal center, with a distance of
7.5 A˚ between the zinc and thew1water (Figure 4A).Water
molecule w2 mediates a network of interactions involving
(1) the ubiquitin R74main-chain carbonyl group and amide
group interacting with Y223 and (2) another water mole-
cule, w3, interacting with the main-chain carbonyl group
of R221 (Figure 4C). The backbone amide of ubiquitin
G76 points to the face of the indole ring of W209, forming
an N-H$$$p electron interaction (Figure 4D). The a carbon
of ubiquitin G76 is within van der Waals contacts with the
aromatic rings of Y259, Y261, andW209 (Figure 4A). Con-
sistent with defects in hydrolysis seen with C-terminally
modified polyubiquitin chains (Wilkinson et al., 1995),
modeling of the G76A mutation of ubiquitin suggests that
the b carbon of alanine would sterically clash with the aro-
matic rings of Y259 and Y261 (data not shown), generating
strong repulsive interactions among the three residues.
The main-chain carbonyl oxygen of ubiquitin G75 forms
two hydrogen bonds with the guanidino group of R221
(Figure 4D); notably, the positively charged R221 side
chain does not interact directly with the carboxylate of
ubiquitin G76. The peptide plane of G75-G76 is in parallel
with the aromatic ring of Y259, whose side-chain hydroxyl
group interacts with D264 (Figure 4E). The negatively
charged side chain of D264 bridges between two argi-
nines (R72 and R74) of ubiquitin (Figure 4E). The aromatic
ring of Y223 from loop L2A packs together with L71 and
L73 of ubiquitin (Figure 4E).
Residues that Contact the Diglycine Motif
of Ubiquitin Are Required for Catalytic
Activation of IsoT
We individually mutated the residues contacting ubiquitin
in the ZnF UBP domain to test their contribution to the
activation of IsoT. These residues are highly conserved
among other ZnF UBP domains (Figure 4F). Seven point
mutants were created, all of which were correctly folded
since over 80% of each point mutant could react with
the active-site-directed irreversible inhibitor Ub-VS (Fig-
ure S1C). All seven point mutants could hydrolyze Ub-
AMC (Figure 5A and Figures S2A–S2B); however, three
of these mutants (W209A, R221A, and Y261A) were not
activated upon addition of free ubiquitin. These three res-
idues are in close contact with the diglycine motif of ubiq-
uitin, suggesting that recognition of diglycine is necessary
for activation of IsoT. In contrast, the remaining four point
mutants, Y223A, F224A, Y261A, and D264A, were acti-
vated upon addition of free ubiquitin, suggesting that con-
tact with residues L8, I36, and L71-R74 of ubiquitin may
not be essential for activation of IsoT.
Although ubiquitin activates Ub-AMC hydrolysis, it does
not activate tetraubiquitin-chain disassembly (Figures
S2C–S2D), suggesting that ubiquitin and the proximalell 124, 1197–1208, March 24, 2006 ª2006 Elsevier Inc. 1201
Figure 3. Structure of IsoT ZnF UBP Domain Bound to Ubiquitin
(A) Ribbon diagram and/or surface representation of the IsoT ZnF UBP domain bound to ubiquitin. Positive charges are represented in blue, negative
charges are shown in red, and neutral residues are shown in white.
(B) Stereo representation of the ZnF UBP domain/ubiquitin complex. The ZnF UBP domain is colored in green, and ubiquitin is colored in gray. I44 and
V70 of the hydrophobic patch of ubiquitin are shown in blue. L8 and I36 of ubiquitin (shown in magenta) interact with F224 of the ZnF UBP domain
(shown in yellow).ubiquitin in the chain occupy the same site. Thus, defects
in the S10 pocket are predicted to result in a decrease in
polyubiquitin-chain hydrolysis. We tested whether one of
the activation-defective IsoT point mutants (R221A) also
exhibited a defect in the disassembly of K48-linked tetrau-
biquitin. As with ubiquitin-dependent modulation of Ub-
AMC hydrolysis, R221A IsoT was also defective in the pol-
yubiquitin-chain hydrolysis (Figures 5B–5C), indicating
that the activation pocket or S10 site has an important
role in the disassembly of a physiological IsoT substrate.1202 Cell 124, 1197–1208, March 24, 2006 ª2006 Elsevier Inc.Recognition of the C Terminus of Ubiquitin
Is Conserved in the ZnF UBP Domain of scIMP
The ZnF UBP domain is a conserved domain present in
other proteins of the ubiquitin system (Figure 4F). To test
whether other ZnF UBP domains recognize ubiquitin by
binding to its C terminus, we cloned and recombinantly
expressed several ZnF UBP domains from other protein
families. Only one of these expressed domains was
soluble and was therefore purified for analysis, scIMP
(YHL010c). scIMP is the S. cerevisiae homolog of human
Figure 4. Interaction between Conserved Residues of the ZnF UBP Domain of IsoT and Ubiquitin
(A) Residues in the C terminus of ubiquitin (gray, carbons; dark blue, nitrogens; orange, sulfurs) interact with the Zn UBP domain (green, carbons; dark
blue, nitrogens; orange, sulfurs). Water molecules and the Zn atom are shown as red spheres.
(B–E) Close-up of the interaction between the IsoT ZnF UBP domain and the C terminus of ubiquitin. Coloring is the same as above. Hydrogen bonds
and electrostatic interactions are represented by black dashes.
(F) Sequence alignment of ZnF UBP domains. The sequence alignment was performedwith ClustalW using theMegAlign software fromDNAStar. The
accession numbers from top to bottom are NP_003472, AAH30704, AAH14176, Q7Z569, AAS56441, AAH18113, NP_006035, and NP_013950. Sec-
ondary structure of the ZnF UBP domain of IsoT is shown above. Dashed lines indicate regions for which electron density was not observed. a helices
are shown as cylinders and b sheets as arrows. The residues that chelate zinc are indicated by an asterisk. Residues that contact ubiquitin are in-
dicated by triangles.Cell 124, 1197–1208, March 24, 2006 ª2006 Elsevier Inc. 1203
Figure 5. ZnF UBP Domain Residues Contacting the Diglycine Motif of Ubiquitin Are Required for Catalytic Activation of IsoT
(A) Effects of mutation of the residues contacting ubiquitin in the ZnF UBP domain of IsoT. E. coli cell lysates (8 ng/ml) expressing wild-type or ZnF UBP
domain mutant IsoT were incubated with 48 nM Ub-AMC. After 100 s, 177 nM Ub was added to the reaction. The fold activation was calculated by
dividing the rate of the reaction after addition of ubiquitin by the rate before the addition of ubiquitin. A Western blot of E. coli cell lysate shows that
equivalent amounts of wild-type or mutant IsoT were expressed (5 mg of cell lysate per lane).
(B) Hydrolysis of K48-linked tetraubiquitin (Ub4) by wild-type, R221A, or C335A IsoT. Equivalent amounts of cell lysate (1.25 ng/ml) expressing WT,
R221A, or C335A were incubated with excess of Ub4 (10 ng/ml) for 7.5, 15, 30, and 60 min.
(C) Western blotting of the E. coli cell lysate expressing WT, R221A, and C335A IsoT (5 mg of cell lysate per lane) shows that equivalent amount of
enzymes were added to the Ub4 hydrolysis reaction shown in (B).
(D) The ZnF UBP domain of S. cerevisiae IMP (scIMP or YHL010c) binds ubiquitin and requires the C-terminal glycine of ubiquitin for binding. Purified
IsoT or scIMP ZnF UBP domain was incubated with Ub, Ub1–75, and control Sepharose beads. Load (L), unbound (U), and bound (B) ZnF UBP domain
were analyzed by SDS-PAGE with SYPRO ruby staining.IMP, sharing significant homology (34% identity) with the
human protein, in particular within the ZnF UBP domain
(65% identity). As shown in Figure 5D, the ZnF UBP do-
main of scIMP (residues 266–389) binds ubiquitin and,
like the ZnF UBP domain of IsoT, fails to bind to Ub1–75
or control resins. These results demonstrate that recogni-
tion of the C terminus of ubiquitin is conserved in another
member of this domain family.
DISCUSSION
The Structure of the ZnF UBP Domain
The structure of the ZnF UBP domain is unique and does
not closely resemble any other known structure. It has
a compact globular fold with a deep cleft and a pocket
that accommodates the C terminus of ubiquitin. A loop
(L2A) forms a ruler that interacts with L8 and I36 on the
face of ubiquitin but not with residues I44 or V70 (Figure 3B
and Figure S1D), which are recognized by other ubiquitin
binding domains (Hicke et al., 2005). Interactions between
ubiquitin and the ZnF UBP domain are largely confined to
this loop and to an extensive network of interactions be-
tween the walls of the ZnF UBP pocket and the C-terminal
residues of ubiquitin. Three tyrosine residues and an argi-
nine line the entrance to the pocket. It is likely that the
initial interaction that results in threading the C terminus
into the ZnF UBP pocket is an electrostatic interaction
between this arginine (R221) and the negatively charged1204 Cell 124, 1197–1208, March 24, 2006 ª2006 Elsevier Inc.C terminus of unanchored polyubiquitin. This interaction
must be followed by a further translocation of the ubiquitin
such that the C terminus is inserted more deeply into the
pocket as contacts are made between the binding surface
of the cleft, as well as with the ruler loop (L2A) and the
surface of ubiquitin containing L8 and I36. The extensive
contacts with the diglycine motif of ubiquitin rationalizes
IsoT’s selectivity for an unmodified ubiquitin C terminus in
binding and hydrolyzing unanchored polyubiquitin chains
and explains the defect in chain disassembly observed
in vivo when G76 is deleted (Amerik et al., 1997).
Residues Involved in Ubiquitin Binding
Are Conserved in Other ZnF UBP Domains
The ZnF UBP domain is present in other proteins of the
ubiquitin system (Figure 4F). These include the HDAC6mi-
crotubule deacetylase; several mammalian deubiquitinat-
ing enzymes; and an E3 ligase, IMP (Amerik et al., 2000;
Ingvarsdottir et al., 2005; Matheny et al., 2004; Quesada
et al., 2004; Seigneurin-Berny et al., 2001). To date only
the ZnF UBP domain of HDAC6 has been shown to bind
ubiquitin (Hook et al., 2002; Seigneurin-Berny et al.,
2001). The results of the present study indicate that two
ZnF UBP domains, those of IsoT and scIMP, are also
capable of binding ubiquitin, but not ubiquitin lacking its
C-terminal glycine (Figure 5D).
The residues participating in ubiquitin recognition are
conserved among other ZnF UBP domains (Figure 4F),
suggesting that the mode of binding may be similar in all
cases. Most of the conserved residues (W209, R221,
Y223, Y259, Y261, and D264) participate in recognition
of the C terminus of ubiquitin by IsoT (Figure 4F). It is un-
clear what role this domain plays in other proteins; pro-
teins that contain this domain might acts as sensors of
ubiquitin or polyubiquitin levels, or they may participate
in the conjugation of preformed polyubiquitin chains to
target proteins. The latter role would be consistent with
the presence of a RING finger ligase domain and a ZnF
UBP domain in IMP. A preformed polyubiquitin chain
could be bound by the ZnF UBP domain via its proximal
end and positioned for the RING domain to catalyze con-
jugation by nucleophilic attack of a lysine of the target pro-
tein on the isopeptide linkage of the proximal ubiquitin.
This simple transpeptidation would result in conjugation
of the preformed chain less the proximal ubiquitin. Either
mechanism could be involved in the observation that over-
expression of UBP14 lowers steady-state levels of poly-
ubiquitin and slows the degradation of some proteins in
yeast (Amerik et al., 1997).
Role of the ZnF UBP Domain in Activation
of Hydrolysis by IsoT
Our data show that the ZnFUBPdomain contributes to the
binding interactions that define the S10 site of IsoT—that
is, the site that binds the proximal ubiquitin in a polyubiqui-
tin chain and that, upon binding monoubiquitin, activates
the hydrolysis of ubiquitin-AMC bound in the S1 site
(Dang et al., 1998; Stein et al., 1995). This activation is de-
pendent upon the presence of an unmodified diglycine
motif on the C terminus of ubiquitin, and our biochemical
data demonstrate that these same requirements are evi-
dent in the binding of ubiquitin to the isolated ZnFUBP do-
main. Mutations in the ZnF UBP domain interfere with the
activation of hydrolysis catalyzed by IsoT. The IsoT point
mutants defective in activation also display a slight de-
crease in the rate of basal Ub-AMC hydrolysis. If the
ZnF-UBP domain and catalytic domain have to interact
for optimal activity, the mutations introduced may disturb
that interaction equilibrium. Alternatively, this difference in
the basal activity between the wild-type and the mutants
may be due to activation of wild-type enzyme by the low
levels of ubiquitin produced early in the hydrolysis of Ub-
AMC. It is unlikely that the UBA domains (S2 and S3) of
IsoT are responsible for activation of IsoT; several struc-
tural studies have conclusively shown that UBA domains
bind to the I44 hydrophobic patch on ubiquitin and not
to its C terminus (Mueller et al., 2004; Ohno et al., 2005;
Varadan et al., 2005). Although our data do not rule out
the possibility that the UBA domains work in conjunction
with the ZnF UBP domain for activation of Ub-AMC hydro-
lysis, they do demonstrate that the ZnF UBP domain is in-
dispensable for this activation.
The conformational change caused by binding of ubiq-
uitin to the S10 site provides a ‘‘proofreading’’ function that
would assure that unanchored chains do not accumulate
but would prevent IsoT from acting on chains until theCconjugated protein/peptide has been removed by other
deubiquitinating enzymes. To understand the nature of
the conformational change that results in activation, we
have compared the structure of the free and liganded do-
main. The only major difference between the structure of
the ZnF UBP domain and the domain with ubiquitin bound
is the orientation of the N terminus of the domain, although
there is3.7 A˚ displacement of loop L2A to accommodate
ubiquitin (Figure S3).The ZnF UBP domain crystallizes as
a dimer linked by a disulfide bond between the C195 res-
idues of both molecules (Figure S4A). The only significant
contact between the two molecules is mediated through
this disulfide bond. The ZnF UBP domain/ubiquitin com-
plex also crystallized as a disulfide-linked dimer, but, un-
like the unliganded domain, it has many intermolecular
contacts formed by a 180º rotation of one monomer with
respect to the other and a domain swap involving the
N-terminal residues 173 to 196 (Figure S4B). Although in
both structures the domain crystallized as a dimer, the di-
merization was not observed in solution (data not shown),
and there is no evidence that the full-length IsoT exists as
a dimer. The significance of the IsoT ZnF UBP domain
swapping is currently unknown; however, the alternative
conformations of the N terminus may suggest that this re-
gion is flexible and thus could have a role in the putative
conformational change that occurs upon activation of
Ub-AMC hydrolysis.
Role of the ZnF UBP Domain
in Polyubiquitin Recognition
IsoT can hydrolyze several different types of polyubiquitin
chains (Raasi et al., 2005). Given that different types of
polyubiquitin chains appear to have different conforma-
tions (Cook et al., 1994; Phillips et al., 2001; Varadan
et al., 2002, 2004), it remains to be determined how IsoT
can bind and hydrolyze all of them. One explanation is
that the alternatively linked chains are flexible enough to
adopt multiple conformations that can be accommodated
by ubiquitin binding domains on IsoT. Another (not mutu-
ally exclusive) explanation is that IsoT has flexible linker re-
gions that connect its different ubiquitin binding domains,
and this flexibility allows the domains to be alternatively
positioned so that they can accommodate each of the al-
ternatively linked polyubiquitin chains. Kinetic and struc-
tural data on IsoT, combined with data on the flexibility
of polyubiquitin chains, suggest that both the enzyme
and the substrate may adapt (Phillips et al., 2001; Stein
et al., 1995; Varadan et al., 2002, 2004).
A highly speculative model for this adaptation arises
from the current structural data on ubiquitin binding to
the ZnF UBP domain. The proximal ubiquitin in the chain
is immobilized at S10 by insertion of the C terminus deeply
into a pocket in the ZnF UBP domain. The lysine residues
involved in linking the next ubiquitin in a polyubiquitin chain
do not contact the ZnF UBP domain, and thus the chain
could project in any direction from the proximal ubiquitin,
depending on the identity of the linkage. To hydrolyze dif-
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ZnF UBP (S10) and the UBP catalytic site (S1) would have
to dramatically change, or the orientation of the bound
proximal ubiquitin would have to vary in order to position
the scissile bond near the catalytic site. We note that it
is possible for the C terminus of the proximal ubiquitin to
rotate like a ratchet in order to accommodate this alterna-
tive binding mode. Since the only significant contacts be-
tween the ZnF UBP domain and the body of ubiquitin are
formed by interaction of the ruler loop L2A and the hydro-
phobic residues L8 and I36, rotation of the proximal ubiq-
uitin about the R72J bond of the C terminus could posi-
tion the proximal ubiquitin so that the ruler loop interacts
instead with I44 and V70. This would allow the positioning
of the scissile bond of alternatively linked polyubiquitin
chains near the catalytic site without requiring so dramatic
a change in the relative orientation of the S1 and S10 sites.
This model is currently being tested.
EXPERIMENTAL PROCEDURES
Fluorescence Anisotropy Measurements
Expression and purification of wild-type and mutant ubiquitins used in
this study have been previously described (Yin et al., 2000). Ubiquitin
bearing the K48C mutation was labeled for fluorescence anisotropy
measurements with the thiol-selective fluorescent dye IAEDANS (5-
((((2-iodoacetyl)amino)ethyl)amino)-naphthalene-1-sulfonic acid) (Mo-
lecular Probes, Inc). Labeling was carried out by reacting 14 mM
K48C ubiquitin in 50 mM Tris (pH 7.5) buffer with 1.5 mM IAEDANS.
The labeling reaction was incubated at 4ºC for 24 hr in the dark fol-
lowed by quenching by addition of 29 mM 2-mercaptoethanol. To re-
move the excess dye, the reaction was dialyzed extensively against
50 mM Tris (pH 7.5). About 95% of K48C ubiquitin was labeled with
IAEDANS to give IA-Ub as determined by HPLC. Fluorescence aniso-
tropy measurements were performed on an AMICO-BOWMAN Series
2 Luminescence Spectrometer at 37ºC. A constant amount of IA-Ub
(80 nM) was incubated with or without wild-type ubiquitin or Ub1–75,
and increasing amounts of wild-type or C199A IsoT were added to
the mixture. Wild-type and C199A IsoT concentrations were deter-
mined using an 3280 of 86,290 cm
1M1 (Gill and von Hipple, 1989).
Binding constants were calculated as described previously (Wilkinson,
2004) using Origin 7.0 software (OriginLab Corporation).
Limited Proteolysis of Full-Length IsoT
Full-length IsoT was expressed in E. coli and purified as previously de-
scribed (Russell and Wilkinson, 2005). To determine the borders of the
ZnF UBP domain, we performed limited proteolysis on the full-length
protein. IsoT was incubated with 1:10 (w/w) trypsin in 50 mM Tris,
1 mM CaCl2, 2 mM 2-mercaptoethanol (pH 8.0). The reaction was in-
cubated at 4ºC for 30 min and then quenched by inactivating trypsin
with PMSF (10 mM final concentration). NaCl and Triton X-100 were
added to the reaction to a final concentration of 150 mM and 10%
(v/v), respectively. To select for a fragment that binds ubiquitin with
an intact C terminus, 40 mg of digested IsoT was incubated with
100 ml of monoubiquitin, G76C monoubiquitin, or control Sepharose
resins for 3 hr at 4ºC. The resins were synthesized by incubating the li-
gands with Sepharose 4B resins preactivated with divinyl sulfone (Her-
manson et al., 1992). After blocking with glycine ethyl ester, the resins
contained 8 mg/ml immobilized protein. After applying the tryptic
digest, the resins were washed three times with 100 ml 50 mM Tris,
2 mM DTT, 150 mM NaCl (pH 7.3). Fragments of IsoT that bound to
the resins were eluted by boiling in 1 SDS loading buffer. The bound
and unbound fractions were analyzed by SDS-PAGE. A 15 kDa frag-
ment that bound the ubiquitin Sepharose resin, but not the G76C or
control resins, was excised from the SDS-PAGE gel and analyzed1206 Cell 124, 1197–1208, March 24, 2006 ª2006 Elsevier Inc.by matrix-assisted laser desorption/ionization mass spectroscopy
(MALDI-MS) and N-terminal sequencing (Microchemical Facility,
Emory University).
Expression and Purification of the ZnF UBP Domains
of IsoT and scIMP
The ZnF UBP domain of IsoT (163–291) was subcloned between the
NdeI and HindIII sites of pRSET B (Invitrogen) using standard molecu-
lar biology methods. Expression was carried out as described for full-
length IsoT. The ZnF UBP domain of IsoT was purified using a ubiquitin
column similar to full-length IsoT (Gabriel et al., 2002; Russell and
Wilkinson, 2005). The purified protein was chromatographed on a
160 ml gel filtration column (Sephacryl S-100 resin) equilibrated with
50mMTris, 150mMNaCl, 2mM b-mecaptoethanol (pH 7.5). Fractions
containing the ZnF UBP domain were identified by SDS-PAGE,
pooled, and concentrated. Protein concentration was measured using
3280 = 23,950 cm
1M1 (Gill and von Hipple, 1989). The ZnF UBP do-
main of scIMP (266–389) was PCR amplified from yeast genomic DNA,
and a His6 tag was introduced at the 5
0 end of the coding sequence.
The amplified DNA was subcloned between the NdeI and HindIII
sites of pRSET B. Expression was carried out as described for the full-
length IsoT, and the protein was purified using Ni-NTA agarose resin
(QIAGEN).
Isothermal Titration Calorimetry
The ZnF UBP domain of IsoT and ubiquitin were dialyzed extensively
against 50 mM Tris-HCl buffer, 150 mM NaCl, 2 mM b-mercaptoetha-
nol (pH 7.5). ITC measurements were carried out in triplicate on a
MicroCal VP-ITC instrument at 30ºC. Ubiquitin (1362 mM) was injected
into 1.4 ml of buffer containing ZnF UBP domain (50 mM) in 35 injec-
tions of 3 ml each. Binding constants were calculated by fitting the
data using Origin 7.0 (OriginLab Corporation).
Site-Directed Mutagenesis of the ZnF UBP Domain
of Full-Length Isopeptidase T
Plasmid DNA encoding full-length IsoT (pRSIsoT) was mutagenized
using the QuikChange Site-Directed Mutagenesis Kit (Stratagene,
Inc). The point mutants were expressed in E. coli as described for
wild-type IsoT. C199A IsoT was purified as described for the wild-
type protein.
Ub-AMC Hydrolysis
Enzymatic activity wasmeasured by incubation of Ub-AMCwith E. coli
cell lysate expressing wild-type or point mutant IsoT at 37ºC in 50 mM
Tris-HCl, 1 mM DTT, 10 mg/ml ovalbumin (pH 7.5). Immunoblots using
rabbit anti-IsoT antibodies generated against the full-length recombi-
nant protein showed that a similar level of expression is achieved in
all cases. The reaction was monitored by following the increase in fluo-
rescence at 440 nm (lex = 340 nm). The activation of Ub-AMC hydro-
lysis by ubiquitin was measured by adding 85 or 117 nM of ubiquitin
100 s after adding IsoT to the Ub-AMC reaction mixture.
K48-Linked Tetraubiquitin Hydrolysis
We incubated 10 ng/ml of tetraubiquitin (Boston Biochem, Inc.) with or
without lysates (1.25 ng/ml) containing recombinant wild-type, R221A,
or C335A IsoT for varying times. The incubationwas carried out at 37ºC
in 50 mM Tris (pH 8.0), 150 mM NaCl, 10 mM b-mercaptoethanol, and
0.5 mg/ml BSA. Samples were analyzed by SDS-PAGE and immuno-
chemical analysis using antibodies to ubiquitin (clone P4D1; Santa
Cruz Biotechnology, Inc.). Immunoblots of the cell lysate using IsoT an-
tibodies showed that equivalent amounts of IsoT point mutants were
added to each reaction.
Ubiquitin Resin Binding
We incubated 40 mg of purified IsoT or scIMP (YHL010c) ZnF UBP
domain (100 ml of 50mMTris [pH 8.0], 150mMNaCl, 10mM b-mercap-
toethanol, and 0.1% Triton X-100) with or without 50 ml of blocked
control, ubiquitin (8 mg/ml), or ubiquitin1–75 (8 mg/ml) conjugated
Sepharose resins, for 3 hr at 4ºC. Equal ratios of bound and unbound
fractions were analyzed by SDS-PAGE and SYPRO ruby staining
(Molecular Probes, Inc).
Crystallography
The ZnF UBP domain of IsoT was concentrated to 32 mg/ml and crys-
tallized by vapor diffusion (2 ml hanging drops over 1 ml reservoirs of
18% polyethylene glycol 8000, 0.1 M sodium cacodylate [pH 6.5],
0.2 M calcium acetate). Crystals (C2 space group) were cryoprotected
in 16% polyethylene glycol 8000, 0.8 M sodium cacodylate (pH 6.5),
0.16 M calcium acetate, 20% glycerol and frozen in liquid nitrogen.
The ZnF UBP domain/ubiquitin complex was prepared by incubating
2-fold molar excess of ubiquitin with the ZnF UBP domain. The com-
plex was separated from unbound ubiquitin by gel filtration (Sephacryl
S-100 resin). The complex was concentrated to 32 mg/ml. The ZnF
UBP domain/ubiquitin complex was crystallized by vapor diffusion
(2 ml hanging drops over 1 ml reservoirs of 16% polyethylene glycol
8000, 0.08 M sodium cacodylate [pH 6.5], 0.16 M magnesium or cal-
cium acetate, and 20% ethylene glycol). The structure of the ZnF
UBP domain was determined utilizing zinc multiwavelength anoma-
lous dispersion (MAD) phasing (Table S1). Three datasets, at wave-
lengths of 1.1281, 1.2790, and 1.2802 A˚, were required for the program
SOLVE to find the positions of two zinc atoms (one for each molecule,
twomolecules per asymmetric unit) to give a solution with a high figure
of merit (0.49 using 2.3 A˚ data cutoff). 176 out of 260 residues were
built and 136 side chains were placed utilizing the RESOLVE iterative
model-building script. The remaining residues were then built manu-
ally, first into the electron density map from the RESOLVE optimized
phases and the partially refined models and then into densities of dif-
ference maps using the program O (Jones and Kjeldgaard, 1997) and
refinement with the program CNS (Brunger et al., 1998). Refinement to
a resolution of 2.09 A˚ was carried out with data collected at 0.97623 A˚
for another crystal. The structure of the complex of the ZnF UBP do-
main with ubiquitin was also solved with zinc MAD phasing using
data collected at the Advanced Photon Source SER-CAT 22-ID beam-
line (Table S2). The program REPLACE (Tong and Rossmann, 1997)
located the position of the ZnF UBP domain by molecular replacement
but could not locate the ubiquitin molecule. The program SOLVE was
used with four wavelength data sets (1.27163, 1.28237, 1.28317, and
1.28855 A˚), and RESOLVE iterative model-building script automati-
cally built most of the ubiquitin molecule and some of ZnF UBP domain
in the complex. A model of the complex was built for refinement by
least-squares fitting of the partially built structure with the previously
determined ZnF UBP domain and a known ubiquitin structure (PDB
ID code 1UBQ) except for a substitution of the C terminus of ubiquitin
with that built by RESOLVE. Refinement to a resolution of 1.99 A˚ was
carried out with data collected at 1.0000 A˚ for another crystal and pro-
ceeded by examination of difference electron densities. In both struc-
tures, there are two molecules/complexes per asymmetric unit. Draw-
ings were produced using PyMOL, USCF Chimera (Pettersen et al.,
2004), and GRASP (Nicholls et al., 1991).
Supplemental Data
Supplemental Data include four figures and two tables and can be
found with this article online at http://www.cell.com/cgi/content/full/
124/6/1197/DC1/.
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